Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-22-014055
Filing Date
2022-08-29
Accepted
2022-08-29 16:56:04
Documents
4
Period of Report
2022-10-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A ampe-20221013xpre14a.htm PRE 14A 200405
2 GRAPHIC ampe-20221013xpre14a001.jpg GRAPHIC 6710
3 GRAPHIC ampe-20221013xpre14a008.jpg GRAPHIC 243794
4 GRAPHIC ampe-20221013xpre14a007.jpg GRAPHIC 227139
  Complete submission text file 0001558370-22-014055.txt   859817
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35182 | Film No.: 221211825
SIC: 2834 Pharmaceutical Preparations